[1]
|
Jenkins, T.A., Nguyen, J.C., Polglaze, K.E. and Bertrand, P.P. (2016) Influence of Tryptophan and Serotonin on Mood and Cognition with a Possible Role of the Gut-Brain Axis. Nutrients, 8, Article No. 56.
https://doi.org/10.3390/nu8010056
|
[2]
|
Rooks, M.G. and Garrett, W.S. (2016) Gut Microbiota, Metabolites and Host Immunity. Nature Reviews Immunology, 16, 341-352. https://doi.org/10.1038/nri.2016.42
|
[3]
|
Sharon, G., Sampson, T.R., Geschwind, D.H. and Mazmanian, S.K. (2016) The Central Nervous System and the Gut Microbiome. Cell, 167, 915-932. https://doi.org/10.1016/j.cell.2016.10.027
|
[4]
|
Foster, J.A., Rinaman, L. and Cryan, J.F. (2017) Stress & the Gut-Brain Axis: Regulation by the Microbiome. Neurobiology of Stress, 7, 124-136. https://doi.org/10.1016/j.ynstr.2017.03.001
|
[5]
|
Gareau, M.G., Wine, E., Rodrigues, D.M., et al. (2011) Bacterial Infec-tion Causes Stress-Induced Memory Dysfunction in Mice. Gut, 60, 307-317. https://doi.org/10.1136/gut.2009.202515
|
[6]
|
Dinan, T.G. and Cryan, J.F. (2013) Melancholic Microbes: A Link between Gut Microbiota and Depression? Neurogastroenterology & Motility, 25, 713-719. https://doi.org/10.1111/nmo.12198
|
[7]
|
Ferreiro, A., Crook, N., Gasparrini, A.J. and Dantas, G. (2018) Multiscale Evo-lutionary Dynamics of Host-Associated Microbiomes. Cell, 172, 1216-1227. https://doi.org/10.1016/j.cell.2018.02.015
|
[8]
|
Human Microbiome Project Consortium (2012) Structure, Function and Diversity of the Healthy Human Microbiome. Nature, 486, 207-214. https://doi.org/10.1038/nature11234
|
[9]
|
Methé, B.A., Nelson, K.E., Pop, M., et al. (2012) A Framework for Human Microbiome Research. Nature, 486, 215-221. https://doi.org/10.1038/nature11209
|
[10]
|
Heiss, C.N. and Olofsson, L.E. (2019) The Role of the Gut Microbiota in De-velopment, Function and Disorders of the Central Nervous System and the Enteric Nervous System. Journal of Neuroendocri-nology, 31, e12684.
https://doi.org/10.1111/jne.12684
|
[11]
|
Lozupone, C.A., Stombaugh, J.I., Gordon, J.I., Jansson, J.K. and Knight, R. (2012) Diversity, Stability and Resilience of the Human Gut Microbiota. Nature, 489, 220-230. https://doi.org/10.1038/nature11550
|
[12]
|
Do, M.H., Lee, E., Oh, M.J., Kim, Y. and Park, H.Y. (2018) High-Glucose or -Fructose Diet Cause Changes of the Gut Microbiota and Metabolic Disorders in Mice without Body Weight Change. Nutrients, 10, Article No. 761.
https://doi.org/10.3390/nu10060761
|
[13]
|
van de Leur, J.J., Vollaard, E.J., Janssen, A.J. and Dofferhoff, A.S. (1997) In-fluence of Low Dose Ciprofloxacin on Microbial Colonization of the Digestive Tract in Healthy Volunteers during Normal and during Impaired Colonization Resistance. Scandinavian Journal of Infectious Diseases, 29, 297-300. https://doi.org/10.3109/00365549709019046
|
[14]
|
Nyberg, S.D., Osterblad, M., Hakanen, A.J., et al. (2007) Long-Term Antimicrobial Resistance in Escherichia coli from Human Intestinal Microbiota after Administration of Clindamycin. Scandina-vian Journal of Infectious Diseases, 39, 514-520. https://doi.org/10.1080/00365540701199790
|
[15]
|
Binder, H.J. (2010) Role of Colonic Short-Chain Fatty Acid Transport in Diarrhea. Annual Review of Physiology, 72, 297-313. https://doi.org/10.1146/annurev-physiol-021909-135817
|
[16]
|
Cryan, J.F. and O’Mahony, S.M. (2011) The Microbi-ome-Gut-Brain Axis: From Bowel to Behavior. Neurogastroenterology & Motility, 23, 187-192. https://doi.org/10.1111/j.1365-2982.2010.01664.x
|
[17]
|
Zhu, X., Han, Y., Du, J., Liu, R., Jin, K. and Yi, W. (2017) Mi-crobiota-Gut-Brain Axis and the Central Nervous System. Oncotarget, 8, 53829-53838. https://doi.org/10.18632/oncotarget.17754
|
[18]
|
Dinan, T.G. and Cryan, J.F. (2015) The Impact of Gut Microbiota on Brain and Behaviour: Implications for Psychiatry. Current Opinion in Clinical Nutrition & Metabolic Care, 18, 552-558.
https://doi.org/10.1097/MCO.0000000000000221
|
[19]
|
Hulme, H., Meikle, L.M., Strittmatter, N., et al. (2020) Microbi-ome-Derived Carnitine Mimics as Previously Unknown Mediators of Gut-Brain Axis Communication. Science Advances, 6, eaax6328. https://doi.org/10.1126/sciadv.aax6328
|
[20]
|
Jackson, M.A., Serena, V., Maxan, M.E., et al. (2018) Gut Mi-crobiota Associations with Common Diseases and Prescription Medications in a Population-Based Cohort. Nature Communica-tions, 9, 2655-2663.
https://doi.org/10.1038/s41467-018-05184-7
|
[21]
|
Pronovost, G.N. and Hsiao, E.Y. (2019) Perinatal Interactions between the Microbiome, Immunity, and Neurodevelopment. Immunity, 50, 18-36. https://doi.org/10.1016/j.immuni.2018.11.016
|
[22]
|
Jameson, K.G., Olson, C.A., Kazmi, S.A. and Hsiao, E.Y. (2020) Toward Understanding Microbiome-Neuronal Signaling. Molecular Cell, 78, 577-583. https://doi.org/10.1016/j.molcel.2020.03.006
|
[23]
|
Agirman, G. and Hsiao, E.Y. (2021) SnapShot: The Microbio-ta-Gut-Brain Axis. Cell, 184, 2524-2524.E1.
https://doi.org/10.1016/j.cell.2021.03.022
|
[24]
|
Dinan, T.G. and Cryan, J.F. (2017) The Microbiome-Gut-Brain Axis in Health and Disease. Gastroenterology Clinics of North America, 46, 77-89. https://doi.org/10.1016/j.gtc.2016.09.007
|
[25]
|
袁伟渠. 针刺对缺血性中风临床疗效及肠道菌群影响的研究[D]: [博士学位论文]. 广州: 广州中医药大学, 2021.
https://doi.org/10.27044/d.cnki.ggzzu.2021.000032
|
[26]
|
Saji, N., Murotani, K., Hisada, T., et al. (2021) The Association between Cerebral Small Vessel Disease and the Gut Microbiome: A Cross-Sectional Analysis. Journal of Stroke and Cerebro-vascular Diseases, 30, Article ID: 105568.
https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105568
|
[27]
|
Nelson, J.W., Phillips, S.C., Ganesh, B.P., et al. (2021) The Gut Microbiome Contributes to Blood-Brain Barrier Disruption in Spontaneously Hypertensive Stroke Prone Rats. The FASEB Journal, 35, e21201.
https://doi.org/10.1096/fj.202001117R
|
[28]
|
Wei, M., Huang, Q., Liu, Z., et al. (2021) Intestinal Barrier Dysfunction Par-ticipates in the Pathophysiology of Ischemic Stroke. CNS & Neurological Disorders—Drug Targets, 20, 401-416.
https://doi.org/10.2174/1871527320666210322115808
|
[29]
|
Tolosa, E., Wenning, G. and Poewe, W. (2006) The Diagno-sis of Parkinson’s Disease. The Lancet Neurology, 5, 75-86. https://doi.org/10.1016/S1474-4422(05)70285-4
|
[30]
|
Xia, Y., Zhang, G., Kou, L., et al. (2021) Reactive Microglia Enhance the Transmission of Exosomal Alpha-Synuclein via Toll-Like Receptor 2. Brain, 144, 2024-2037. https://doi.org/10.1093/brain/awab122
|
[31]
|
Travagli, R.A., Browning, K.N. and Ca-milleri, M. (2020) Parkinson Disease and the Gut: New Insights into Pathogenesis and Clinical Relevance. Nature Reviews Gastroenterology & Hepatology, 17, 673-685.
https://doi.org/10.1038/s41575-020-0339-z
|
[32]
|
Qian, Y., Yang, X., Xu, S., et al. (2020) Gut Metagenomics-Derived Genes as Potential Biomarkers of Parkinson’s Disease. Brain, 143, 2474-2489. https://doi.org/10.1093/brain/awaa201
|
[33]
|
Romano, S., Savva, G.M., Bedarf, J.R., et al. (2021) Meta-Analysis of the Parkinson’s Disease Gut Microbiome Suggests Alterations Linked to Intestinal Inflammation. npj Parkinson’s Disease, 7, 27.
https://doi.org/10.1038/s41531-021-00156-z
|
[34]
|
Cirstea, M.S., Yu, A.C., Golz, E., et al. (2020) Microbiota Composi-tion and Metabolism Are Associated with Gut Function in Parkinson’s Disease. Movement Disorders, 35, 1208-1217. https://doi.org/10.1002/mds.28052
|
[35]
|
Wang, Y., Tong, Q., Ma, S.R., et al. (2021) Oral Berberine Improves Brain Do-pa/Dopamine Levels to Ameliorate Parkinson’s Disease by Regulating Gut Microbiota. Signal Transduction and Targeted Therapy, 6, 77.
https://doi.org/10.1038/s41392-020-00456-5
|
[36]
|
Olek, M.J. (2021) Multiple Sclerosis. Annals of Internal Medicine, 174, ITC81-ITC96.
https://doi.org/10.7326/AITC202106150
|
[37]
|
Cox, L.M., Maghzi, A.H., Liu, S., et al. (2021) Gut Microbiome in Pro-gressive Multiple Sclerosis. Annals of Neurology, 89, 1195-1211. https://doi.org/10.1002/ana.26084
|
[38]
|
Pröbstel, A.K., Zhou, X., Baumann, R., et al. (2020) Gut Microbiota-Specific IgA+ B Cells Traffic to the CNS in Active Multiple Sclerosis. Science Immunology, 5, eabc7191. https://doi.org/10.1126/sciimmunol.abc7191
|
[39]
|
Cignarella, F., Cantoni, C., Ghezzi, L., et al. (2018) Intermittent Fasting Confers Protection in CNS Autoimmunity by Altering the Gut Microbiota. Cell Metabo-lism, 27, 1222-1235.E6. https://doi.org/10.1016/j.cmet.2018.05.006
|
[40]
|
Tankou, S.K., Regev, K., Healy, B.C., et al. (2018) A Probiotic Modulates the Microbiome and Immunity in Multiple Sclerosis. Annals of Neurology, 83, 1147-1161. https://doi.org/10.1002/ana.25244
|
[41]
|
Scheltens, P., De Strooper, B., Kivipelto, M., et al. (2021) Alzheimer’s Disease. The Lancet, 397, 1577-1590.
https://doi.org/10.1016/S0140-6736(20)32205-4
|
[42]
|
李丹, 林萍, 金伟峰, 陈姝子, 李萍, 程训佳. 阿尔茨海默病患者糖、脂代谢与脂多糖的相关性[J]. 检验医学, 2020, 35(11): 1126-1129.
|
[43]
|
Kesika, P., Suganthy, N., Sivamaruthi, B.S. and Chaiyasut, C. (2021) Role of Gut-Brain Axis, Gut Microbial Composition, and Probiotic Intervention in Alzheimer’s Dis-ease. Life Sciences, 264, Article ID: 118627.
https://doi.org/10.1016/j.lfs.2020.118627
|
[44]
|
Kim, M.S., Kim, Y., Choi, H., et al. (2020) Transfer of a Healthy Microbi-ota Reduces Amyloid and Tau Pathology in an Alzheimer’s Disease Animal Model. Gut, 69, 283-294. https://doi.org/10.1136/gutjnl-2018-317431
|
[45]
|
Marizzoni, M., Cattaneo, A., Mirabelli, P., et al. (2020) Short-Chain Fatty Acids and Lipopolysaccharide as Mediators between Gut Dysbiosis and Amyloid Pathology in Alzheimer’s Disease. Journal of Alzheimer’s Disease, 78, 683-697.
https://doi.org/10.3233/JAD-200306
|
[46]
|
Wang, X., Sun, G., Feng, T., et al. (2019) Sodium Oligomannate Therapeuti-cally Remodels Gut Microbiota and Suppresses Gut Bacterial Amino Acids-Shaped Neuroinflammation to Inhibit Alzheimer’s Disease Progression. Cell Research, 29, 787-803. https://doi.org/10.1038/s41422-019-0216-x
|
[47]
|
Kaur, H., Nagamo-to-Combs, K., Golovko, S., et al. (2020) Probiotics Ameliorate Intestinal Pathophysiology in a Mouse Model of Alzheimer’s Disease. Neurobiology of Aging, 92, 114-134.
https://doi.org/10.1016/j.neurobiolaging.2020.04.009
|
[48]
|
Liang, J., Sha, S.M. and Wu, K.C. (2014) Role of the Intestinal Microbiota and Fecal Transplantation in Inflammatory Bowel Diseases. Journal of Digestive Diseases, 15, 641-646. https://doi.org/10.1111/1751-2980.12211
|
[49]
|
Liu, R.T., Walsh, R.F. and Sheehan, A.E. (2019) Prebiotics and Probiotics for Depression and Anxiety: A Systematic Review and Meta-Analysis of Controlled Clinical Trials. Neuroscience & Biobehav-ioral Reviews, 102, 13-23.
https://doi.org/10.1016/j.neubiorev.2019.03.023
|
[50]
|
高燕. 1例双侧额叶脑挫裂伤合并反复腹泻行粪菌移植患者的护理[J]. 中西医结合心血管病电子杂志, 2018, 6(1): 197-198.
|
[51]
|
Galen, J.E. and Collmer, A. (1999) Type III Secretion Machines: Bacterial Devices for Protein Delivery into Host Cells. Science, 284, 1322-1328. https://doi.org/10.1126/science.284.5418.1322
|
[52]
|
Winter, G., Hart, R.A., Charlesworth, R. and Sharpley, C.F. (2018) Gut Microbiome and Depression: What We Know and What We Need to Know. Reviews in the Neurosciences, 29, 629-643. https://doi.org/10.1515/revneuro-2017-0072
|
[53]
|
Silva de Carvalho, T., Singh, V., Yusuf, A.M., et al. (2022) Post-Ischemic Protein Restriction Induces Sustained Neuroprotection, Neurological Recovery, Brain Remodeling, and Gut Mi-crobiota Rebalancing. Brain, Behavior, and Immunity, 100, 134-144. https://doi.org/10.1016/j.bbi.2021.11.016
|